Return to search

Oaktree Buying Evonik Cyanide Assets

Evonik has agreed to sell its U.S. and Canadian cyanide activities to Oaktree Capital Management for an undisclosed amount. Publicly-traded Evonik recently received a 1.6 billion investment from CVC, while Oaktree recently agreed to buy Nevada Chemicals. www.oaktreecapital.com